This page shows the latest migraine news and features for those working in and with pharma, biotech and healthcare.
It has added to its pipeline under Dunsire with a $1.95bn takeover of Alder Biopharma, adding migraine prevention therapy Vyepti (eptinezumab) – which is launching in competition with rival drugs from
Once launched it will also have to compete with Eli Lily’s new acute migraine therapy Reyvow (lasmiditan), a first-in-class 5H-T. ... it offers patients a chance at freedom from migraine pain and their most bothersome symptom…at two hours”.
Lilly’s migraine med Emgality receives negative opinion for label extension. The European Medicines Agency’s advisory Committee for Medicinal Products for Human Use has recommended only one new drug and ... one generic medicine at its latest meeting,
US regulator clears CGRP inhibitor under Vyepti trade name. Lundbeck has the payoff it was looking for from its acquisition of Alder Biopharma last year, claiming FDA approval for migraine prevention ... specialists aren’t rushing to switch wholesale
It’s one of a clutch of new drugs – that also includes migraine prevention therapy Ajovy (fremanezumab) – that Teva needs to perform well and help it recover from the double whammy
The sales growth comes despite tougher competition in the market from new migraine drugs as well as rivals like Dysport in its medical aesthetics indications. ... Allergan chief executive Brent Saunders said Allergan is entering 2020 with “strong
More from news
Approximately 26 fully matching, plus 148 partially matching documents found.
as multiple sclerosis and migraine, to monitor their health and track the success of their medication. ... To create Rain Free Days, we worked closely with staff and patients at the National Migraine Centre and Prof Zameel Cader at The John Radcliffe
Eli Lilly/Dong Pharmaceuticals’ 5-HT1f agonist Reyvow was approved in the US in October 2019 as the first acute treatment for migraine in 20 years. ... Allergan’s Ubrelvy is the only other oral CGRP antagonist approved for acute migraine, which
pipeline. He argues, however, that layering in products like Allergan’s blockbuster wrinkle and migraine treatment Botox will improve near-term cashflow and help fund the roll-out of a new ... year. Botox is facing tougher competition in the market
Published adherence in migraine-prophylaxis (as a comparable indication) indicates 92.6% adherent at one month, 40.7% at two months, 30.9% at three months, 24.8% at four months,
Teva’s CGRP patent portfolio to develop, manufacture and commercialise eptinezumab, its phase III CGRP antibody for the treatment of migraine. In exchange for the licence, Alder will withdraw its appeal
More from intelligence
Approximately 1 fully matching, plus 26 partially matching documents found.
He brings sales and marketing experience from Johnson &Johnson, and served as franchise marketing director for psychiatry, Parkinson's disease and migraine products at Novartis.
Prior to joining the agency, Morgan worked on accounts in patient advocacy for cancer immunotherapy, hepatitis C treatments and migraines for Firstlight PR and Hill and Knowlton Strategies.
operations. This includes ensuring the success of current products, such as Sumavel DosePro for migraine, as well as soon to be launched products, such as Zohydro, which is pending FDA approval
More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.
Women suffer from migraines three times as often as men.
You may not realise it, but colour impacts migraines. 11 London worked with Teva Pharmaceuticals UK, Dulux Paints and the National Migraine Centre to test this theory among 1, 200 migraine ... Many factors can trigger a migraine - even something as
Migraine market snapshot. Research Partnership’s migraine market snapshot offers an introduction to the real world patient data collected by their Therapy Watch migraine study.
Living with Chronic Pain is a quantitative study conducted online amongst 390 US patients with diabetic neuropathic pain, chronic lower back pain, cancer pain and headache/migraine pain.
As for Martin, DDB Remedy won a Silver and Two bronze awards for an integrated campaign for Excedrin, an OTC migraine treatment in the US, helping to address the issue that ... people often respond to someone with a migraine by just saying that it’s
More from PMHub
Approximately 1 fully matching, plus 8 partially matching documents found.
Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....